Literature DB >> 17013901

Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer.

Feng Wang-Johanning1, Jinsong Liu, Kiera Rycaj, Miao Huang, Kate Tsai, Daniel G Rosen, Dung-Tsa Chen, Danielle W Lu, Kirstin F Barnhart, Gary L Johanning.   

Abstract

Individual classes of human endogenous retrovirus (HERV) genes and proteins are expressed in cancer, but expression of more than one type of HERV is rare. We report here the expression of multiple HERV genes and proteins in ovarian cell lines and tissues. Expression of HERV-K env mRNA was greater in ovarian epithelial tumors than in normal ovarian tissues (N = 254). The expression of this protein on the surface and in the cytoplasm of ovarian cancer cells was confirmed using anti-HERV-K specific antibody by flow cytometric analysis. The frequency of expression of HERV-K env protein in multitissue microarrays (N = 641) was determined by immunohistochemistry and a significant correlation with tumor histotype was found. A significantly increased expression of HERV-K was observed in tumors with low malignant potential and low grade, relative to expression in normal ovarian tissues. The increase in expression of HERV-K env protein took place in a stepwise fashion in serous papillary adenocarcinoma. Interestingly, we found that other classes of HERV env mRNAs, including ERV3 and HERV-E, are expressed in the same ovarian cancer tissues that expressed HERV-K. Furthermore, anti-HERV antibodies including anti-ERV3 (30%), anti-HERV-E (40%) and anti-HERV-K (55%) were detected in patients with ovarian cancer, but not in normal female controls. HERV env proteins are frequently transcribed and translated in ovarian epithelial tumors, and multiple HERV families are detectable in ovarian cancer. HERV env proteins, and especially those expressed on the cell surface, may serve as novel tumor targets for detection, diagnosis and immunotherapy of ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17013901     DOI: 10.1002/ijc.22256

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  91 in total

1.  Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.

Authors:  Katherine B Chiappinelli; Pamela L Strissel; Alexis Desrichard; Huili Li; Christine Henke; Benjamin Akman; Alexander Hein; Neal S Rote; Leslie M Cope; Alexandra Snyder; Vladimir Makarov; Sadna Budhu; Sadna Buhu; Dennis J Slamon; Jedd D Wolchok; Drew M Pardoll; Matthias W Beckmann; Cynthia A Zahnow; Taha Merghoub; Taha Mergoub; Timothy A Chan; Stephen B Baylin; Reiner Strick
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

2.  HBV X Protein induces overexpression of HERV-W env through NF-κB in HepG2 cells.

Authors:  Cong Liu; Lijuan Liu; Xiuling Wang; Youyi Liu; Miao Wang; Fan Zhu
Journal:  Virus Genes       Date:  2017-06-20       Impact factor: 2.332

3.  Expression of Human Endogenous Retrovirus Type K Envelope Protein is a Novel Candidate Prognostic Marker for Human Breast Cancer.

Authors:  Jing Zhao; Kiera Rycaj; Shanshan Geng; Ming Li; Joshua B Plummer; Bingnan Yin; Hong Liu; Xu Xu; Yinchun Zhang; Yanfang Yan; Sharon A Glynn; Tiffany H Dorsey; Stefan Ambs; Gary L Johanning; Lin Gu; Feng Wang-Johanning
Journal:  Genes Cancer       Date:  2011-09

4.  HEMO, an ancestral endogenous retroviral envelope protein shed in the blood of pregnant women and expressed in pluripotent stem cells and tumors.

Authors:  Odile Heidmann; Anthony Béguin; Janio Paternina; Raphaël Berthier; Marc Deloger; Olivia Bawa; Thierry Heidmann
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

5.  Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma.

Authors:  Janani Krishnamurthy; Brian A Rabinovich; Tiejuan Mi; Kirsten C Switzer; Simon Olivares; Sourindra N Maiti; Joshua B Plummer; Harjeet Singh; Pappanaicken R Kumaresan; Helen M Huls; Feng Wang-Johanning; Laurence J N Cooper
Journal:  Clin Cancer Res       Date:  2015-03-31       Impact factor: 12.531

6.  Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma.

Authors:  Christof C Smith; Kathryn E Beckermann; Dante S Bortone; Aguirre A De Cubas; Lisa M Bixby; Samuel J Lee; Anshuman Panda; Shridar Ganesan; Gyan Bhanot; Eric M Wallen; Matthew I Milowsky; William Y Kim; W Kimryn Rathmell; Ronald Swanstrom; Joel S Parker; Jonathan S Serody; Sara R Selitsky; Benjamin G Vincent
Journal:  J Clin Invest       Date:  2018-10-02       Impact factor: 14.808

Review 7.  Viruses associated with human cancer.

Authors:  Margaret E McLaughlin-Drubin; Karl Munger
Journal:  Biochim Biophys Acta       Date:  2007-12-23

8.  Comparative methylation of ERVWE1/syncytin-1 and other human endogenous retrovirus LTRs in placenta tissues.

Authors:  Juliette Gimenez; Cécile Montgiraud; Guy Oriol; Jean-Philippe Pichon; Karine Ruel; Vassilis Tsatsaris; Pascale Gerbaud; Jean-Louis Frendo; Danièle Evain-Brion; François Mallet
Journal:  DNA Res       Date:  2009-06-27       Impact factor: 4.458

Review 9.  Human endogenous retroviruses and cancer: causality and therapeutic possibilities.

Authors:  Christina S Mullins; Michael Linnebacher
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

10.  OVEX1, a novel chicken endogenous retrovirus with sex-specific and left-right asymmetrical expression in gonads.

Authors:  Danièle Carré-Eusèbe; Noëlline Coudouel; Solange Magre
Journal:  Retrovirology       Date:  2009-06-17       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.